Yi Xiang Su

Mr. Yi Xiang Su

Monash University Malaysia, School Of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
YKYew Rong Kong
Yew Rong Kong
KTKai Ching Tay
Kai Ching Tay
YSYi Xiang Su
Yi Xiang Su
CWChoon Kwang Wong
Choon Kwang Wong
WTW.N. Tan
W.N. Tan
KKKooi Yeong Khaw
Kooi Yeong Khaw
Alkaloids are a class of secondary metabolites that can be derived from plants, fungi and marine sponges. They are widely known as a continuous source of medicine for the management of chronic disease including cancer, diabetes and neurodegenerative diseases. For example, galanthamine and huperzine A are alkaloid derivatives currently being used for the symptomatic management of neurodegenerative disease. The etiology of neurodegenerative diseases is polygenic and multifactorial including but not limited to inflammation, oxidative stress and protein aggregation. Therefore, natural-product-based alkaloids with polypharmacology modulation properties are potentially useful for further drug development or, to a lesser extent, as nutraceuticals to manage neurodegeneration. This review aims to discuss and summarise recent developments in relation to naturally derived alkaloids for neurodegenerative diseases.